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Background: We hypothesized that women are more prone to develop coronary
dissections during PCI due to potential balloon over-sizing or gender specific plaque or
vascular characteristics. To date, such a difference in edge dissection has not been
systematically studied.
Methods: The MGH OCT Registry is an international registry of patients undergoing
PCI. We identified 206 patients (159 men, 47 women) with stable angina or acute
coronary syndrome with adequate OCT images for gender specific comparison in areas of
non-overlapping stents. Presence of proximal/distal edge dissections, characteristics of
dissections, underlying plaque composition at stent borders and luminal diameters were
assessed and compared. A multivariate logistic regression model was applied to determine
if female gender was independently predictive of coronary dissection after adjusting for
clinical and OCT characteristics.
Results: Women had smaller mean reference vessel diameter (2.89 mm vs 3.07 mm,
p0.04) when compared to men. No gender difference was observed in age, clinical
characteristics, presentation, stents per patient or plaque characteristics. Incidence and
characteristics of edge dissections were different in women compared to men (Table1).
These data showed that female gender (OR: 2.3, p0.02) was an independent predictor
of coronary dissection. Hypertension (OR: 2.1, p0.03), plaque calcification at distal edge
(OR: 4.6 p0.02), lipid rich plaque at proximal edge (OR: 3.1 p0.01) and lipid rich
plaque at distal edge (OR: 3.4, p0.01) were independently associated with the
development of stent edge dissection.
Characteristics Female (N47) Male (N 159) p-value
Any Dissection 24 (49%) 50 (29.9%) 0.02
Distal Dissection 9 (18.4%) 24 (14.4%) 0.5
Prox.Dissection 15 (30.6%) 26 (15.6%) 0.02
Prox. Flap Length 0.27 0.54 mm 0.09 0.26 mm 0.01
Prox. Dissection Length 0.53 0.98 mm 0.17 0.44 mm 0.01
Ratio of Stent/ Prox. Ref.
Diameter 1.2
4 (8.2%) 11 (6.6%) 0.7
Conclusions: OCT confirms that women have approximately a two-fold increased risk
of developing coronary edge dissections as compared to men. The unique characteristics
of gender associated dissections (proximal edge, flap length) warrant further investigation
into gender specific device-vessel wall interactions.
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Background: Stent thrombosis (ST) is a rare but devastating adverse event. The
Academic Research Consortium proposed a standard classification of the ST based on the
elapsed time since stent implantation: early ST (EST) 0-30 days, late ST (LST)30 days,
and very late ST 12 months. The multicenter Spanish Registry ESTROFA suggested
that the patients with EST and LST presented a different clinical profile, which may
correlate with a different physiopathology mechanism. The aim of this study is to describe
the differences between EST and LST analysing the clinical characteristics, therapeutic
management and intravascular ultrasound (IVUS) findings.
Methods: Patients with demonstrated ST presented in a single centre were collected.
Demographic, procedural variables and treatment was recorded. ST were divided in two
groups: EST and LST (30 days).Statistics were performed with SPSS 14.0.
Results: 45 ST were detected:23 EST(11 of them acute ST) and 22LTS(7 very LST).16
were bare metal ST and 29 were drug-eluting ST. Patients with EST were el-
der(68,511,7 vs 59,812,6) and had more diabetes(63,6%vs34,8%). Multivessel
disease was more frequent in the group of LST. The mortality rate was higher in the group
of EST (30% against 4,5% for LST).The vessel most frequently affected was the LAD for
ETS (43,5%) and the RCA for LTS (54,5%). The stent overlap was more frequent in the
group of LST and the maximal pressure of delivery was higher in the group of EST. IVUS
was performed in 19 cases. The most notable IVUS finding in the group of LST was the
under-expansion of the stent(60%) with a significant intrastent proliferation in20%of
cases. In the group of EST,a dissection at the edge of the stent was more frequent, with
significant under-expansion and uncovered culprit lesion as secondary findings.The LTS
was treated with a new stent in 50% of cases. In the EST the most frequent management
was the thrombectomy followed by postdilatation.
Conclusions: The physiopathologic mechanism of the ETS and LST seems to be
different. A specific treatment for each entity could be necessary. The IVUS is an
invaluable tool in the matter of ST, providing precise information of the mechanism of ST
and guiding the best therapeutic choice.
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Background: Higher incidence of drug-eluting stent (DES) restenosis after bifurcation
stenting has been suggested. Delayed healing is another problematic issue associated with
bifurcation stenting. We assessed restenotic tissue characteristics after DES deployment at
bifurcation using optical coherence tomography (OCT).
Methods: One hundred and fourteen angiographically documented in-stent restenotic
lesions of five types of first- and second-generation DES (sirolimus-DES: 50%, paclitaxel-
DES: 24%, zotarolimus-DES: 3%, everolimus-DES: 20%, biolimus-DES 3%) in 90
patients were included. OCT appearance of restenotic tissue was qualitatively assessed.
Restenotic tissue luminal morphology, such as eccentric, concentric and protruded, was
also assessed. Morphometric analysis such as measurement of minimal lumen area
(MLA), stent area at MLA, neointimal hyperplasia (NIH) at MLA were performed. All
variables were compared between restenotic lesions at bifurcation (BIF) vs. those at
non-bifurcation (non-BIF).
Results: Among 34 bifurcation lesions (30%), 32 lesions (94%) were related with left
main trunk bifurcation. Restenosis occurred at 730696 days after initial deployment.
Patient and lesion characteristics were similar except more female (38 % vs.16 %,
p0.015) and chronic kidney disease on hemodialysis (35 % vs. 14%, p0.02), and
higher incidence of focal stenosis (94% vs. 49%, p0.001) in BIF vs. non-BIF. OCT
tissue appearance, such as homogeneous (64% vs. 76%), attenuated (20% vs. 24%) and
heterogeneous (16% vs. 0%) were differently distributed in BIF vs. non-BIF, particularly
heterogeneous type was exclusively observed in non-BIF (p0.04). Protruded tissue
morphology tended to be more frequent in BIF vs. non-BIF (12% vs. 1%, p0.06).
Although MLA (2.31.2cm 2 vs. 1.60.8cm2, p0.003) and stent area at
MLA(7.12.5cm 2 vs. 6.11.8cm2, p0.04) were larger, NIH at MLA (4.82.4cm 2
vs. 4.51.7cm2, p0.4) were similar in BIF vs. non-BIF.
Conclusions: Different restenotic tissue characteristics were identified by OCT at
bifurcation after DES deployment. This may depict a peculiar healing mechanism
correlated with DES deployed at bifurcation.
TCT-250
Predictors of In Stent Restenosis by Optical Coherence Tomography Derived
Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model
Of Familial Hypercholesterolemic Swine
Piotr Buszman1, Taylor Palmieri1, Maxwell Afari1, Armando Tellez1,
Yanping Cheng1, Jong Shiuan Yeh1, Seung-Jin Oh1, Greg Kaluza1, Juan Granada1
1Cardiovascular Research Foundation, Orangeburg, NY
Background: Several publications have shown the potential for in vivo neointimal
characterization using OCT-based light intensity backscattering. Several neointimal
patterns have been described and correlated with histopathology. Nevertheless, the clinical
significance of these findings is unclear. In this study, we aimed to seek for predictors of
in-stent restenosis (ISR) based on OCT tissue characterization analysis in a novel
peripheral artery model of familial hypercholesterolemic swine (FHS).
Methods: A total of 15 arterial segments of 8 FHS were enrolled. At baseline balloon
injury followed by self-expandable stent implantation was performed. Two weeks after,
each site underwent OCT with tissue characterization followed by POBA. All animals
were then followed for additional 28 days. Morphometric OCT analysis was performed
before POBA and at follow up. At last follow up, stent segments were labeled as ISR
(75%) according to percent area of stenosis (%AS) by OCT. Tissue characterization by
OCT included neointimal structure and light backscatter analysis following previously
published definitions. Each stent was divided into 5 segments along the longitudinal axis
and matched with corresponding cross sections at follow up.
Results: A total of 75 stent segments were analyzed in which ISR occurred in 18.7%.
Mean %AS was 21.715% before treatment and 56.622% at termination (p0.01).
Sections presenting with ISR, had higher %AS (34.1 vs. 12.3%;p0.01), occurrence of
heterogeneous neointima (64.3% vs. 19.7%; p0.01) and low tissue backscattering
(42.8% vs. 26.7%; p0.01) at 14 days. In the multivariate analysis the presence of a
heterogenous neointima (OR:5.9 [1.2-28.2], p0.01) and low tissue backscattering
(OR:2.9 [1.1-7.8]; p0.01) were the only independent predictors of ISR at 28 days,
regardless of baseline %AS (OR:53.6 [0.1-42797];p0.24).
Conclusions: The presence of heterogeneous neointima and low light tissue backscat-
tering appears to predict the risk of restenosis by 6 and 3 fold respectively. These findings
could assist in the decision making process and guide the selection of the most appropriate
therapeutic strategy for ISR.
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